Annual revenue fell from KRW 18 billion in 2022 to KRW 14.8 billion in 2023, down 17.3%, then rose to KRW 17.8 billion in 2024 (up 20.2%) and KRW 22.8 billion in 2025 (up 27.7%), growing for two consecutive years after 2023. 2025 was the largest year of the 2022–2025 span, and the company said its 2025 revenue was the highest since its founding.
Operating profit dropped from KRW 5.64 billion in 2022 to KRW 1.38 billion in 2023 (down 75.6%), then rose to KRW 2.58 billion in 2024 (up 87.3%) and KRW 3.94 billion in 2025 (up 52.6%), increasing for two consecutive years after 2023.
The operating margin fell from 31.4% in 2022 to 9.3% in 2023 and has recovered to 14.5% in 2024 and 17.3% in 2025, but it has not returned to the 2022 level. Against the company's disclosed target of an operating margin of at least 20% each year from 2026 to 2028, the 2025 figure is still below.
Controlling-shareholder net income was KRW 7.13 billion in 2022, KRW 4.7 billion in 2023 (down 34.1%), KRW 5.82 billion in 2024 (up 23.7%) and KRW 4.69 billion in 2025 (down 19.4%). Net income including non-controlling interests, which is a different figure, was KRW 4.6 billion in 2025.
In the first half of 2026, operating profit fell about KRW 300 million year on year, which the company attributed to higher personnel costs, depreciation on test equipment and expenses from expanding its subsidiary business, per reporting dated August 18, 2026.
Quarterly revenue went from KRW 5.05 billion in Q3 2025 to KRW 5.78 billion in Q4 2025 (up 14.3% quarter on quarter), KRW 6.24 billion in Q1 2026 (up 7.9%), KRW 6.59 billion in Q2 2026 (up 5.7%) and KRW 6.76 billion in Q3 2026 (up 2.5%), rising for four consecutive quarters from Q4 2025 through Q3 2026; Q3 2026 revenue was up 33.8% year on year.
Quarterly operating profit rose from KRW 452 million in Q3 2025 to KRW 752 million in Q4 2025, KRW 959 million in Q1 2026 and KRW 1.51 billion in Q2 2026, then fell 20.0% quarter on quarter to KRW 1.21 billion in Q3 2026.
In Q1 2026, some health functional food projects were delayed, which pushed back revenue recognition; revenue fell 3.4% and operating profit fell 49.8% year on year, per reporting on the May 15, 2026 disclosure.
Controlling-shareholder net income swung from a net loss of KRW 877 million in Q4 2025 to a profit of KRW 1.49 billion in Q1 2026, then fell to KRW 579 million in Q3 2026, down 62.1% quarter on quarter and 63.7% year on year.
Net income attributable to controlling shareholders over the last four quarters totaled KRW 2.72 billion. Preliminary nine-month figures announced on November 16, 2026 showed revenue of KRW 19.6 billion and operating profit of KRW 3.7 billion, each up about 15% year on year.
Quarterly swings in profit appear to depend heavily on the timing of project schedules and the spending on staff and equipment.